FDA guidance
Guidance for the Content of Premarket Notifications for Intracorporeal Lithotripters…
FDA guidance · issued Nov 30, 1998
Key facts
| Title | Guidance for the Content of Premarket Notifications for Intracorporeal Lithotripters - Guidance for Industry |
|---|---|
| Issue date | Nov 30, 1998 |
At a glance
- 10–99 Product codes referenced
- 1–9 Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents